Finding the right medication for adolescents struggling with mental health challenges can be a complex and frustrating process. At Aerie Healthcare, we understand that each individual responds differently to psychotropic medications. That’s why we offer GeneSight® testing to our Partial Hospitalization Program (PHP) participants, as an option to provide a more personalized and effective approach to medication management.

What Is GeneSight Testing?

GeneSight is a pharmacogenomic test that analyzes a person’s genetic makeup to predict how they may metabolize or respond to various psychotropic medications. While not 100% accurate, this advanced tool helps our clinicians make more informed prescribing decisions, reducing the trial-and-error process that often leads to unwanted side effects or ineffective treatment.

Why It Matters for Adolescents in PHP

Adolescents in PHP often face acute mental health challenges, requiring a careful balance of therapy and medication. GeneSight testing enhances this process by:

✔ Improving Medication Selection – Helps our psychiatrists choose medications that align with the adolescent’s genetic profile, increasing the likelihood of positive outcomes.

✔ Reducing Side Effects – Identifies medications that may cause adverse reactions, allowing for a more targeted and tolerable treatment plan.

✔ Enhancing Treatment Efficiency – Shortens the time it takes to find an effective medication, so adolescents can experience symptom relief sooner.

✔ Empowering Families – Provides valuable insight to parents and caregivers, helping them feel more confident in their child’s treatment plan.

At Aerie Healthcare, we are committed to using cutting-edge tools like GeneSight to ensure that every adolescent in our PHP receives the most effective, individualized care. By integrating genetic testing into our approach, we help young people regain stability and focus on what truly matters—their mental health and well-being.

For more information about our adolescent PHP program, contact Aerie Healthcare today!